L'Oréal (OR.PA) analysis

Loading the Vaultflake…

Health is the debt of three books, not of a brand that cannot be left. Quality separates the mass-market margin from luxury and from dermocosmetics. Growth follows jars sold, not a year of many launches. P/E is read against that year, not against that peak as normal. Shareholder return is the dividend, checked against cash. Do not read it as growth that does not break.

The P/E of a year of heavy luxury is not the earnings if China softens. EV/EBITDA is read without treating dermocosmetics as if they were the lipstick. Do not use LVMH's multiple, which combines fashion and wine, as if the jar and the bag were the same book. A dash if the OR.PA cache is cold.

Limits of this report

Not advice on L'Oréal. Vaultflake does not describe the formula and does not treat growth as uninterrupted. Read the filings. A past dividend is not a right. The table is a snapshot, not a target price.

Questions from this report